Hemo Organic Share Price

CMP as on21-Jan-22 15:43

₹ 12.35
-0.65 -5%

Open

₹ 13.65

Turnover (lac)

Prev. Close

₹ 13.00

Day's Vol (shares)

₹ 1,579

Day's Range

₹ 12.35
₹ 13.65

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 02-Nov-2021 - -
Quarterly Results In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on November 13, 2021, at the Registered Office of the Company which was commenced at 05:00 P.M. and concluded at 05:45 P.M., has apart from other businesses, considered, approved and taken on record the Unaudited Financial Result of the Company for the quarter ended on September 30, 2021 along with Limited Review Report. Unaudited Financial Result of the Company has been unloaded separately. (As Per BSE Announcement dated on 13.11.2021)
Board Meeting - 05-Aug-2021 - -
Quarterly Results Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve and take on record the Un-audited Financial Result of the Company for the quarter ended on June 30, 2021 as per Regulation 33 of the Listing Regulation and any other items as may be decided by the Board of Directors We hereby submit the outcome of Board Meeting held on today. (As Per BSE Announcement Dated on 11.08.2021)
Board Meeting - 24-Jun-2021 - -
Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of our Company is scheduled to be held on Wednesday, June 30, 2021 at the registered office of the Company situated at 8-A, Gulnar, Chinar - Gulnar Appt. V V Nagar Road Anand -388001, to consider, approve and take on record the Audited Financial Result of the Company for the quarter and year ended on March 31, 2021 as per Regulation 33 of the Listing Regulation and any other items as may be decided by the Board of Directors. In this connection and in continuation of our intimation regarding Closure of Trading Window for the Insiders of the Company vide letter dated March 31, 2021, the trading window for dealing in the securities of the Company is already closed for the Insiders of the Company since Thursday, April 1, 2021. In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on June 30, 2021, at the Registered Office of the Company which was commenced at 05:45 P.M. and concluded at 06:30 P.M., have 1. Considered, approved and took on record the audited financial Statement for the financial year ended on March 31, 2021. 2. Considered, approved and took on record the audited financial result for the quarter and year ended on March 31, 2021 along with Audit Report (Modified Opinion) and Statement on Impact of Audit Qualifications (for Audit Report with Modified Opinion). (As Per BSE Announcement Dated on 30/06/2021)
Board Meeting - 08-Feb-2021 - -
Hemo Organic Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2021 ,inter alia, to consider and approve & take on record the Unaudited Financial Result of the Company for the quarter ended on December 31, 2020 as per Regulation 33 of the Listing Regulation and any other items as may be decided by the Board of Directors This is clarified that today the Company has intimated the Board Meeting date for approval of quarterly result. In this regard we wish to clarify that in the Subject and letter submitted by the Company, the date of Board meeting has inadvertently written as Tuesday, February 9, 2021. The stakeholders are requested to read the date Tuesday, February 9, 2021 as Saturday, February 13, 2021. We attached herewith the revised Intimation Letter. In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on today, i.e. on February 13, 2021, at the Registered Office of the Company which was commenced at 05:30 P.M. and concluded at 06:10 P.M., have, apart from other businesses, considered, approved and taken on record the Unaudited Financial Results of the Company for the quarter ended on December 31, 2020 along with Draft Limited Review Report. Kindly take the same on your record and oblige us. (As per BSE Announcement Dated on 13/2/2021)
Open ZERO Brokerage Demat Account Open ZERO Brokerage Demat Account

  • 0

    Delivery Brokerage for Lifetime

  • 20

    Per order for Intraday, F&O, Currency & Commodity